Clinics in Dermatology
Volume 27, Issue 6 , Pages 594-596 , November 2009

Sentinel lymph node biopsy from the vantage point of an oncologic surgeon

  • Lori L. Wilson, MD

      Affiliations

    • Corresponding Author InformationTel.: +1 860 679 2290; fax: +1 860 679 1202.

References 

  1. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317
  2. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, and international multicenter trial. Ann Surg. 2005;242:302–311
  3. Habal N, Giuliano AE, Morton DL. The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer. Semin Oncol. 2001;28:41–52
  4. Morton DL, Cagle L, Wong J. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. In: Presented at the 42nd Annual Meeting of the Society of Surgical Oncology, Washington, DC, May 20-22. 1990;
  5. Morton DL, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  6. Rousseau DL, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol. 2003;10:569–574
  7. Gershenwald JE, Mansfield PF, Lee JE, et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol. 2000;7:160–165
  8. Jacobs IA, Chang CK, Salti GI. Role of sentinel lymph node biopsy in patients with thick (>4 mm) primary melanoma. Am Surg. 2004;70:59–62
  9. Carlson GW, Murray DR, Hestley A, et al. Sentinel lymph node biopsy for thick (> or =4 mm) melanoma: should we be doing it?. Ann Surg Oncol. 2003;10:408–415
  10. Thompson JF, Shaw HM. The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome?. Ann Surg Oncol. 2004;11:247–258
  11. Essner R, Chung MH, Bleicher R, et al. Prognostic implications of thick (> or =4 mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy. Ann Surg Oncol. 2002;9:754–761
  12. Cochran AJ, Ohsie SJ, Binder SW. Pathobiology of the sentinel node. Curr Opin Oncol. 2008;20:190–195
  13. Thompson JF, Uren RF. Teaching points on lymphatic mapping for melanoma from the Sydney Melanoma Unit. Semin Oncol. 2004;31:349–356
  14. Essner R, Bostick PJ, Glass EC, et al. Standardized probe-directed sentinel node dissection in melanoma. Surgery. 2000;127:26–31

PII: S0738-081X(08)00194-6

doi: 10.1016/j.clindermatol.2008.09.017

Clinics in Dermatology
Volume 27, Issue 6 , Pages 594-596 , November 2009

Article Tools